In terms of inflammation biomarker, C reactive protein, procalcitonin, and percentage of neutrophil did not differ significantly between the two groups, while white blood cell count in the anti-tumor therapy group was significantly lower than the control group (p = 0.001), which was correlated with the existence of myelosuppression in these patients (Table 3). This evidence concerns the gene CRP and neoplasm.